Molecular Mechanisms and Targets

All Items

• 

  VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels

  Chunyu Zhu, Yameng Cheng, Yao Yu, Yanning Zhang, Guiyun Ren

  1244–1257
• 

  VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

  Lidija Todorović, Boban Stanojević

  26-36
• 

  Unveiling the impact of C15orf48 on non-small cell lung cancer through NF-kappa B signaling

  Wei Wang, Lei Zhang, Ansheng Wang, Xiaohua Wang, Weidong Wu

  1162–1174
• 

  Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy

  Semir Vranic, Zoran Gatalica

  673–675
• 

  Tumor glucose reprogramming suppresses cuproptosis: A review

  Xiao-Hang Song, Yi-Hang Ding, Jing-Song Chen

  251–261
• 

  Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling

  Hongyan Zhang, Ruiqing Zong, Huiqi Wu, Jun Jiang, Chuanyong Liu, Suiyi Liu

  1606–1619
• 

  The mechanism of high mobility group box-1 protein and its bidirectional regulation in tumors

  Zhongjia Tian, Lin Zhu, Yutong Xie, Huan Hu, Qunli Ren, Jianguo Liu, Qian Wang

  477–485
• 

  Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level

  Xingchao Song, Wenjin Li, Chunyan Tian, Xiao Ma, Weibin Yang, Jiahua Zhou

  144–154
• 

  Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway

  Hongmei Yin, Zhongxia Yuan, Xiumei Han, Die Jiang, Duojie Li, FengLi Song

  1150–1161
• 

  SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

  Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

  1231–1243
• 

  Secreted frizzled-related protein 4 (sFRP4) in cancer – Dual roles in tumorigenesis and therapeutic potential: A review

  Yu Jiang, Luyao Wang, Yerong Li, Juan Liu, Juan Lv, Pengfei Xu

  274–284
• 

  Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis

  Ge Yu, Xiaoling Feng

  82–93
• 

  Role and mechanism of KIAA1429 in regulating cellular ferroptosis and radioresistance in colorectal cancer

  Hao Chen, Peipei Zhu, Dan Zhu, Juan Jin, Qianni Yang, Xiaodong Han

  1669–1681
• 

  Research progress and application status of organoid in breast cancer subtypes

  Qiuxia Zhang, Min Wang, Li You, Chen Chen, Jia Feng, Miao Song, Kui Yang, Xuexue Liu, Guangrong Li, Jinbo Liu

  976–985
• 

  Reconsideration of the laminin receptor 67LR in colorectal cancer cells

  Gabriel Cloutier, Jean-François Beaulieu

  1117–1132
• 

  Quercetin regulates sensitivity to X-ray radiation of hepatocellular carcinoma through miR-216a-3p

  Nuran Bedolla, Linyu Liu, Qiuxian Xie, Xueting Liu, Yanli Ren

  833–849
• 

  Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis

  Juncai Li, Jianguo Yang, Zhenzhou Chen, Li Liu, Hao Wang, Qican Deng, Yajun Chen, Yong Que, Zhongxue Fu

  483–495
• 

  Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

  Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

  161-169
• 

  Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V

  Changchang Lu, Lu Zou, Qiaoli Wang, Mengna Sun, Tianyu Shi, Shuang Xu, Fanyan Meng, Juan Du

  1424–1434
• 

  Piperine inhibits the proliferation of colorectal adenocarcinoma by regulating ARL3-mediated endoplasmic reticulum stress

  Chenqu Wu, Yanqing Qian, Jun Jiang, Deming Li, Li Feng

  391–405